NCT01644305已完成不适用
1. Association of Plasma GDF-9 or GDF-15 Levels With Bone Parameters in Polycystic Ovary Syndrome. 2. Plasma GDF-15 Levels and Their Association With Hormonal and Metabolic Status in Women With Polycystic Ovary Syndrome Aged 25-35.
Ankara Education and Research Hospital1 个研究点 分布在 1 个国家目标入组 85 人开始时间: 2012年7月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 85
- 试验地点
- 1
- 主要终点
- The association of GDF 9 AND GDF 15 with bone and cardiovascular parameters in women with polycystic ovary syndrome
研究概览
简要总结
The purpose of this study is to determine the plasma levels of GDF-9 and GDF-15, and their association with bone and cardiovascular parameters in patients with Polycystic Ovary Syndrome.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 25 Years 至 35 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Female patients at ages 25-35 diagnosed with polycystic ovarian syndrome and idiopathic hirsutism
排除标准
- •acute infectious disease, a thyroid, pituitary, nutritional, inflammatory, hepatic, renal, or neoplastic disorder; history of cardiovascular disease or pulmonary embolism; a family history of coronary artery disease; smoking history; hypertension; diabetes mellitus; use of oral contraceptives, anti-androgens and drugs known to interfere with cytokine release, such as corticosteroids, immunosuppressors, or nonsteroidal antiinflammatory drugs.
- •any medication known to affect hormonal or metabolic parameters.
结局指标
主要结局
The association of GDF 9 AND GDF 15 with bone and cardiovascular parameters in women with polycystic ovary syndrome
时间窗: 1 year
次要结局
未报告次要终点
研究者
Zehra Berberoglu
Ass. Prof.
Ankara Education and Research Hospital
研究点 (1)
Loading locations...
相似试验
尚未招募
Unknown
The ASPIRE Trial - understanding the impact of mucositis on cachexia in head and neck cancerhead and neck cancermucositiscachexiaCancer - Head and neckInflammatory and Immune System - Other inflammatory or immune system disordersOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonMusculoskeletal - Other muscular and skeletal disordersACTRN12623000521628niversity of Adelaide25
进行中（未招募）
不适用
GDF-15 levels as prognostic marker in patients with Atrial FibrillatioGrowth and differentiation Factor-15C14.280.067.198RBR-106xbn9sniversidade Federal Fluminense
Unknown
不适用
Use of GDF15 as a Biomarker for Early Diagnosis of DM and Monitoring of Progress of Complications in AsiansDiabetic PolyneuropathyDiabetic NephropathiesDiabetes Mellitus, Type 2NCT04119167Chang Gung Memorial Hospital500
招募中
不适用
Stroke-induced Myocardial Dysfunction: Role of GDF-15 (SMOG-15) Clinical Work PackageIschemic StrokeNCT05683873Centre Hospitalier Universitaire Dijon130
Unknown
不适用
Correlation Between Fluorodeoxyglucose (FDG) and FLT Uptake and Gene-Expression Oncotype Assay in Patients With Breast CancerBreast CancerNCT00688337Tel-Aviv Sourasky Medical Center100